- Home
- DQ vs QDEL Comparison
DQ vs QDEL Comparison
Compare DQ & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DQ | QDEL |
|---|---|---|
| Founded | 2006 | 1979 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | DQ | QDEL |
|---|---|---|
| Price | $27.00 | $28.71 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 6 |
| Target Price | $32.50 | ★ $40.00 |
| AVG Volume (30 Days) | 806.9K | ★ 950.8K |
| Earning Date | 02-26-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $639,063,000.00 | ★ $2,714,400,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $60.25 | $2.42 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.41 | $19.50 |
| 52 Week High | $36.59 | $46.24 |
Technical Indicators
Market Signals| Indicator | DQ | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 44.06 | 43.74 |
| Support Level | $23.96 | $27.19 |
| Resistance Level | $28.76 | $35.58 |
| Average True Range (ATR) | 1.24 | 2.16 |
| MACD | 0.09 | -0.68 |
| Stochastic Oscillator | 42.74 | 19.80 |
Price Performance
Historical ComparisonAbout DQ DAQO New Energy Corp.
Daqo New Energy Corp is a polysilicon manufacturer based in China. The company manufactures and sells high-purity polysilicon to manufacturers who use it to make ingots, cells, and modules for solar power solutions. The polysilicon is packaged to meet crucible stacking, pulling, and solidification needs. All of the company's revenues come from the People's Republic of China.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.